246 related articles for article (PubMed ID: 35711161)
1. Evaluation of Procalcitonin's Utility to Predict Concomitant Bacterial Pneumonia in Critically Ill COVID-19 Patients.
Patel N; Adams C; Brunetti L; Bargoud C; Teichman AL; Choron RL
J Intensive Care Med; 2022 Nov; 37(11):1486-1492. PubMed ID: 35711161
[No Abstract] [Full Text] [Related]
2. The utility of procalcitonin for diagnosing bacteremia and bacterial pneumonia in hospitalized oncology patients.
Munsell MK; Fadelu T; Stuver SO; Baker KP; Glotzbecker B; Simmons JL; Reynolds KL; Patel AK
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5193-5204. PubMed ID: 36371720
[TBL] [Abstract][Full Text] [Related]
3. Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients.
Galli F; Bindo F; Motos A; Fernández-Barat L; Barbeta E; Gabarrús A; Ceccato A; Bermejo-Martin JF; Ferrer R; Riera J; Peñuelas O; Lorente JÁ; de Gonzalo-Calvo D; Menéndez R; Gonzalez J; Misuraca S; Palomeque A; Amaya-Villar R; Añón JM; Balan Mariño A; Barberà C; Barberán J; Blandino Ortiz A; Bustamante-Munguira E; Caballero J; Cantón-Bulnes ML; Carbajales Pérez C; Carbonell N; Catalán-González M; de Frutos R; Franco N; Galbán C; Lopez Lago A; Gumucio-Sanguino VD; de la Torre MDC; Díaz E; Estella Á; Gallego Curto E; García-Garmendia JL; Gómez JM; Huerta A; Jorge García RN; Loza-Vázquez A; Marin-Corral J; Martin Delgado MC; Martínez de la Gándara A; Martínez Varela I; Lopez Messa J; M Albaiceta G; Nieto MT; Novo MA; Peñasco Y; Pérez-García F; Pozo-Laderas JC; Ricart P; Sagredo V; Sánchez-Miralles A; Sancho Chinesta S; Roche-Campo F; Socias L; Solé-Violan J; Suarez-Sipmann F; Tamayo Lomas L; Trenado J; Úbeda A; Valdivia LJ; Vidal P; Boado MV; Rodríguez A; Antonelli M; Blasi F; Barbé F; Torres A;
Intensive Care Med; 2023 Aug; 49(8):934-945. PubMed ID: 37507573
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of procalcitonin in hospitalized COVID-19 patients and clinical outcomes of antibiotic use stratified by procalcitonin levels.
So W; Simon MS; Choi JJ; Wang TZ; Williams SC; Chua J; Kubin CJ
Intern Emerg Med; 2022 Aug; 17(5):1405-1412. PubMed ID: 35277828
[TBL] [Abstract][Full Text] [Related]
5. Negative predictive value of procalcitonin to rule out bacterial respiratory co-infection in critical covid-19 patients.
Carbonell R; Urgelés S; Salgado M; Rodríguez A; Reyes LF; Fuentes YV; Serrano CC; Caceres EL; Bodí M; Martín-Loeches I; Solé-Violán J; Díaz E; Gómez J; Trefler S; Vallverdú M; Murcia J; Albaya A; Loza A; Socias L; Ballesteros JC; Papiol E; Viña L; Sancho S; Nieto M; Del M; Lorente C; Badallo O; Fraile V; Arméstar F; Estella A; Abanses P; Sancho I; Guasch N; Moreno G;
J Infect; 2022 Oct; 85(4):374-381. PubMed ID: 35781017
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic value of serum procalcitonin for infection in the immunocompromised critically ill patients with suspected infection].
Yu X; Ma X; Ai Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Jun; 27(6):477-83. PubMed ID: 26049187
[TBL] [Abstract][Full Text] [Related]
7. Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis.
Pfister R; Kochanek M; Leygeber T; Brun-Buisson C; Cuquemelle E; Machado MB; Piacentini E; Hammond NE; Ingram PR; Michels G
Crit Care; 2014 Mar; 18(2):R44. PubMed ID: 24612487
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19.
Pink I; Raupach D; Fuge J; Vonberg RP; Hoeper MM; Welte T; Rademacher J
Infection; 2021 Oct; 49(5):935-943. PubMed ID: 34021897
[TBL] [Abstract][Full Text] [Related]
9. [The prognostic value of serum procalcitonin on severity of illness in non-sepsis critically ill patients].
Ma J; Wang S; Chen D; Duan J; Li C; Li G
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Aug; 28(8):688-93. PubMed ID: 27434557
[TBL] [Abstract][Full Text] [Related]
10. Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients.
Dolci A; Robbiano C; Aloisio E; Chibireva M; Serafini L; Falvella FS; Pasqualetti S; Panteghini M
Clin Chem Lab Med; 2020 Nov; 59(2):433-440. PubMed ID: 33554505
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic and predictive value of critical illness scores and biomarkers in bloodstream infection-associated pneumonia].
Yan S; Sun L; Lian R; Shen M; Zhao X; Zhang G
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jun; 32(6):681-685. PubMed ID: 32684212
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.
Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK
J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357
[TBL] [Abstract][Full Text] [Related]
13. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.
Hoshina T; Nanishi E; Kanno S; Nishio H; Kusuhara K; Hara T
J Infect Chemother; 2014 Oct; 20(10):616-20. PubMed ID: 25027057
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of serum procalcitonin in identifying the etiology of non-responding community-acquired pneumonia after initial antibiotic therapy].
Wang Z; Zhang X; Wu J; Zhang W; Kuang H; Li X; Xuan W; Wang K; Ma L
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Nov; 37(11):824-30. PubMed ID: 25604112
[TBL] [Abstract][Full Text] [Related]
15. High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department.
Tong-Minh K; van der Does Y; Engelen S; de Jong E; Ramakers C; Gommers D; van Gorp E; Endeman H
BMC Infect Dis; 2022 Feb; 22(1):165. PubMed ID: 35189826
[TBL] [Abstract][Full Text] [Related]
16. [Value of Hepcidin as a diagnostic biomarker of sepsis in critically ill adults].
Qiu Z; Shen K; Shu M; Xu D; Deng X; Chen D
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):652-657. PubMed ID: 30045792
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and Prognostic Utility of Procalcitonin in Patients Presenting to the Emergency Department with Dyspnea.
Alba GA; Truong QA; Gaggin HK; Gandhi PU; De Berardinis B; Magrini L; Bajwa EK; Di Somma S; Januzzi JL;
Am J Med; 2016 Jan; 129(1):96-104.e7. PubMed ID: 26169892
[TBL] [Abstract][Full Text] [Related]
18. Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort study.
Daubin C; Parienti JJ; Fradin S; Vabret A; Ramakers M; Terzi N; Freymuth F; Charbonneau P; du Cheyron D
BMC Infect Dis; 2009 Sep; 9():157. PubMed ID: 19772586
[TBL] [Abstract][Full Text] [Related]
19. The utility of initial procalcitonin and procalcitonin clearance for prediction of bacterial infection and outcome in critically ill patients with autoimmune diseases: a prospective observational study.
Shi Y; Peng JM; Hu XY; Wang Y
BMC Anesthesiol; 2015 Oct; 15():137. PubMed ID: 26446077
[TBL] [Abstract][Full Text] [Related]
20. Procalcitonin Levels in Critically Ill Children With Status Asthmaticus.
Samraj RS; Crotty EJ; Wheeler DS
Pediatr Emerg Care; 2019 Oct; 35(10):671-674. PubMed ID: 31593980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]